Vyriad, a Mayo Clinic spinoff that is developing genetically-engineered viruses for the treatment of various forms of cancer, will use 25,000 square feet of space on the site for offices, research and the production of the company's clinical-stage oncolytic virus therapies.
Thank you for eight great years!
Med City Beat is no longer publishing new articles, though archives from 2014-2022 remain accessible to the public.